Clinical Trials Sponsored by Immunex/Berlex

Total 3494 results

Herlev Hospital

Unknown

Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock

Septic Shock

Denmark
Herlev Hospital

Completed

Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery

Smoking | Breast Cancer

Denmark
Herlev Hospital

Unknown

Laryngoscope Prototype Tested Against the Traditional Macintosh Blade

Anesthesia, Intravenous

Denmark
Herlev Hospital

Unknown

Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis

Ulcerative Colitis

Denmark
Herlev Hospital

Unknown

Low-Dose Endotoxemia and the Acute Phase Response

Sepsis | Endotoxemia

Denmark
Immune-Onc Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

CMML | AML With Monocytic Differentiation

United States
Robert Ferris
Immune Cell Therapy Inc.

Withdrawn

Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Mayo Clinic
University of Chicago; Immune Tolerance Network (ITN)

Completed

A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation

Transplantation, Liver

United States
Pelex

Recruiting

Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.

Stress Urinary Incontinence | Pelvic Floor Disorders

United States
Pelex

Completed

Efficacy of a Non-invasive Pelvic Floor Muscle Trainer for Treatment of Stress Urinary Incontinence

Urinary Incontinence | Stress Urinary Incontinence | Pelvic Floor Disorders

United States
Immutep S.A.S.
Merck Sharp & Dohme LLC

Recruiting

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC (TACTI-003)

HNSCC

United States, Belgium, Spain, United Kingdom, Denmark, Germany, Australia, Romania, Ukraine
Centre Hospitalier Universitaire Vaudois
Immutep S.A.S.

Terminated

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

Melanoma

Switzerland
Immutep S.A.S.
SGS Aster-Cephac (CRO)

Completed

A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321

Healthy

France
Bionor Immuno AS
Celgene Corporation

Completed

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)

HIV-1 Infection

Germany
Bionor Immuno AS
Celgene Corporation

Completed

Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (REDUC)

HIV I Infection

Denmark
University of Miami
Immuno Laboratories

Completed

IgG-mediated Food Test for Weight Loss

Overweight and Obesity

United States
Charite University, Berlin, Germany
Technische Universität Berlin; Humboldt-Universität zu Berlin

Active, not recruiting

Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations (Paracentesis)

Paracentesis

Germany
University Hospital Inselspital, Berne
Charite University, Berlin, Germany; Goethe University; University of Basel

Completed

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study (CoRisk)

Stroke | Transient Ischemic Attack

Germany, Switzerland
Charite University, Berlin, Germany
Medical School Berlin

Recruiting

Neuromodulation and Mindfulness Patients With AUD

Alcohol Dependence

Germany
Charite University, Berlin, Germany
Technische Universität Berlin

Completed

Plethysmographic Pulse-contour and Pulse-wave-transit-times for Haemodynamic Evaluation in Bleeding Simulation (Plethysmo)

Health, Subjective

Germany
Freie Universität Berlin
Charite University, Berlin, Germany

Completed

Maintaining Mechanisms of Chronic Depression and Their Changeability (GetWell)

Major Depressive Disorder
Charite University, Berlin, Germany
Freie Universität Berlin

Unknown

Cognitive Training to Improve Cognitive Function Following Chemotherapy (KT)

Cognitive Dysfunction

Germany
University Hospital Inselspital, Berne
University of Bern; Werner und Hedy Berger-Janser - Stiftung

Completed

Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation (HEAD-MET)

Head and Neck Cancer | Oral Cavity Squamous Cell Carcinoma

Switzerland
Charite University, Berlin, Germany
Center for Stroke Research Berlin; Medical Institute BMW-Berlin Marathon, Berlin...

Completed

Berlin Beat of Running Study

Stroke | Cardiac Arrhythmia | Brain Lesion

Germany
Charite University, Berlin, Germany
Technische Universität Berlin

Recruiting

Healing Light Algorithms for Nurses in the ICU (ENGAGE-ICU)

Critical Care | Phototherapy

Germany
Charite University, Berlin, Germany
Medical School Berlin

Completed

Neural Mechanisms of Tactile Priming on Social Perceptions - Pilot Study

Healthy

Germany
Changhai Hospital
Shanghai Ultra-T Immune Therapeutics Co. LTD

Not yet recruiting

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System

Digestive Tumor
Immune Enhancement Project

Completed

Acupuncture and Herbal Treatment of Chronic HIV Sinusitis

HIV Infections | Sinusitis

United States
Charite University, Berlin, Germany
Humboldt-Universität zu Berlin; Stiftung Deutsche Klassenlotterie Berlin

Unknown

Exposure Initializes Therapy - Treatment Of Homebound Patients Extended (ExITTOHoPE)

Agoraphobia

Germany
Charite University, Berlin, Germany
Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-Weißensee

Completed

Art Therapy in Acute Schizophrenia (KUSS)

Schizophrenia

Germany
ImmunOs Therapeutics AG
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Solid Tumor, Adult

Australia
Assistance Publique - Hôpitaux de Paris
Fonds IMMUNOV

Completed

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (AMBUCOV)

Covid19 | SARS-CoV-2

France
Timmune Biotech Inc.
Hunan Provincial People's Hospital

Unknown

Treatment of Hematological Malignancy With Novel CAR-T Cells.

Multiple Myeloma | B-cell Acute Lymphoblastic Leukemia | B-cell Non Hodgkin Lymphoma

China
Immuno Cure 3 Limited
The University of Hong Kong

Active, not recruiting

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

COVID-19

Hong Kong
Charite University, Berlin, Germany
NeuroCure Clinical Research Center, Charite, Berlin; Humboldt-Universität zu... and other collaborators

Terminated

Computerised Assessment of Visual Neglect Symptoms in Peripersonal Space (KMS-Neglect 2)

Visual Neglect

Germany
Shanxi Province Cancer Hospital
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Recruiting

Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Tunisian Association for Immuno-oncology Research

Not yet recruiting

Biomarkers in Patients With Metastatic Breast Cancer (BIOPEACE)

Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
Charite University, Berlin, Germany
International Psychoanalytic University Berlin

Completed

Modified Psychodynamic Psychotherapy for Patients With Schizophrenia (MPP-S)

Schizophrenia | Schizoaffective Disorder

Germany
Charite University, Berlin, Germany
Berlin Institute of Health

Active, not recruiting

Urinary T Cell Biomarker for Prediction in Lupus Nephritis

Lupus Nephritis

Germany, United Kingdom
Charite University, Berlin, Germany
Berlin Institute of Health

Unknown

Arthrocentesis Study

Periprosthetic Joint Infection | Septic Arthritis

Germany
Charite University, Berlin, Germany
Immanuel Hospital, Berlin, Germany

Completed

Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting (MIFT)

Healthy Volunteers

Germany
Shanxi Province Cancer Hospital
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Recruiting

Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma

Lymphoma, B-Cell

China
Alpine Immune Sciences, Inc.
Clinical Network Services (CNS) Pty Ltd

Completed

Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety

Healthy Volunteers

Australia
Theresa Whiteside, PhD
Immune Cell Therapy Inc.

Terminated

Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer (NSCLC)

United States
The Immune Response Corporation

Completed

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

HIV Infections

United States
The Immune Response Corporation

Completed

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

HIV Infections

United States
Charite University, Berlin, Germany
Berlin Institute of Health

Recruiting

TransCranial Doppler for REDUCtion of Silent strokE During MitraClip Implantation (TCD-REDUCE)

Mitral Valve Insufficiency

Germany
International Psychoanalytic University Berlin
Charite University, Berlin, Germany

Terminated

Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction (BFD)

Dream Disorder | Thrombotic Infarction | PCA Infarct

Germany
Charite University, Berlin, Germany
Berlin Institute of Health

Active, not recruiting

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Glomerulonephritis Acute

United Kingdom, Germany
Humboldt-Universität zu Berlin
Charite University, Berlin, Germany

Completed

Effectiveness of Isometric vs. Eccentric Exercise in Chronic Achilles Tendinopathy

Tendinopathy

Germany

Clinical Trials Sponsored by Immunex/Berlex

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations